Find your next paid study

Roswell Park Cancer InstituteNCT06434064

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

A Participant- and Investigator--Blinded, Placebo- Controlled, Randomized, Multipart, Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease

The purpose of this first-in-human (FIH) study is to evaluate safety, tolerability, pharmacokinetic (PK) of OJR520.

Chronic Kidney Disease

Novartis PharmaceuticalsNCT07235059

~$500 – $10,500

Actual pay is set by the research site.

Evaluation of the Bexa Breast Examination (BBE) as an Effective Solution to Breast Cancer Early Detection

Objective: The "Bexa Breast Exam," or "BBE," for the purposes of this study is defined as the use of a Bexa device in conjunction with a portable, focused ult…

Breast Cancer

Post-Acute COVID-19 SyndromeME/CFSRheumatic Arthritis+41 more

~$10 – $1,050

Actual pay is set by the research site.

Sure, Inc.NCT06643767

Unhide® Project Also Known as The Unhide® Solve Together Unified Platform

The unhide® Project is a non-interventional, longitudinal research study designed to establish a secure data repository of demographic, health, and lifestyle i…

~$10 – $1,125

Catecholaminergic Polymorphic Ventricular Tachycardia

A Phase 2, Double-Blind, Repeat-Dose, Placebo-Controlled Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CRD-4730 In Participants With Catecholaminergic Polymorphic Ventricular Tachycardia

This is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability,…

Cardurion Pharmaceuticals, Inc.NCT06658899

~$75 – $2,800

Actual pay is set by the research site.

Muscle ToneMuscle Strength

Safety and Efficacy of Pure Impact to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles

Open-label, non-randomized, prospective, single-center, self-controlled clinical study.

Sofwave Medical LTDNCT07094971

~$10 – $1,050

Actual pay is set by the research site.

A Phase 2, Open-label, Multicenter Study of MB-105 in Patients With CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r/r TCL).

This is a single arm, two-stage, Phase 2, open-label, multicenter study of MB-105 in patients with CD5 Positive (CD5+) Relapsed / Refractory T-cell Lymphoma (r…

Lymphoma, T-Cell

March Biosciences IncNCT06534060

~$75 – $2,800

Actual pay is set by the research site.

Targeting Cognitive Control to Improve Physical Activity Adherence in Midlife for Alzheimer's Risk Reduction

This trial is designed to develop and test the efficacy of cognitive training strategies to improve self-regulatory capacities for middle-aged adults to adopt …

Physical Inactivity

University of IowaNCT06338774

~$10 – $750

Actual pay is set by the research site.

A Phase 2, Multicenter, Open-label Study of Lifileucel (Tumor-infiltrating Lymphocytes [TIL]) in Participants With Previously Treated Advanced Endometrial Cancer.

The purpose of this study is to investigate the efficacy and safety of the lifileucel regimen in participants with previously treated endometrial cancer.

Endometrial Cancer

Iovance Biotherapeutics, Inc.NCT06481592

~$75 – $2,800

Actual pay is set by the research site.

Large B-cell LymphomaRelapsed Non-Hodgkin Lymphoma

Phase 2, Single-Arm Trial of Comprehensive Ablative Bridging Irradiation (CABI) Prior to CD19 CAR-T Cell Therapy in High-Risk, Relapsed or Refractory Large B Cell Lymphoma in Patients With Bulky Disease

This is a phase 2, single-arm, open-label study to evaluate the safety and efficacy of comprehensive bridging radiation therapy prior to CD19 CAR T-cell therap…

H. Lee Moffitt Cancer Center and Research InstituteNCT06104592

~$75 – $2,000

Actual pay is set by the research site.

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

Previous studies provide a rationale for administration of AZA after allo SCT for decreasing chimerism. The investigators hypothesize that azacitidine can be w…

Myeloid Malignancy

Henry Ford Health SystemNCT03850418

~$75 – $2,000

Actual pay is set by the research site.

MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke

This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (…

Subacute Stroke